Prospective study of the efficacy of intravesical chemotherapy with THP against subsequent bladder cancer after nephrouretectomy (NUx) for upper urinary tract carcinoma (UUTC).
Not Applicable
Recruiting
- Conditions
- rothelial carcinoma of upper urinary tract
- Registration Number
- JPRN-UMIN000005767
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Prior bladder cancer Carcinoma in situ, or treatment history for carcinoma in situ Severe diabetes Uncontrollable complications Severe mental diseases Active multiple cancers Anthracycline sensitivity Patients diagnosed as inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bladder recurrence free rate.
- Secondary Outcome Measures
Name Time Method Disease-specific survival. Safety.